Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for Chronic Obstructive Pulmonary Disease (COPD)
Drugs which address the underlying tissue damage in COPD and prevent the progressive decline in lung function which is a hallmark of this disease are urgently needed.